Antares Pharma reported $28.54M in Gross Profit on Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Adma Biologics ADMA:US $ 0.38M 1.39M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Atrion ATRI:US 17.79M 77K
Becton, Dickinson and BDX:US $ 2254M 93M
Cerus CERS:US $ 24.52M 2.08M
Eli Lilly And LLY:US $ 5342M 555.1M
Endo International Ordinary Shares ENDP:US $ 474.91M 74.51M
Horizon Pharma HZNP:US $ 785.35M 153.8M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Meridian Bioscience VIVO:US $ 44.72M 7.61M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Pfizer PFE:US $ 14163M 2178M
Revance Therapeutics RVNC:US $ 13.86M 481K
Rockwell Medical RMTI:US $ -0.33M 0.07M
Sientra SIEN:US 10.59M 675K
Staar Surgical STAA:US $ 45.3M 3.9M
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
Zogenix ZGNX:US $ 21.32M 3.75M